Sign In

Jeff Haxer

Partner, Global Leader of Divestitures Product, Leader in M&A Healthcare Practice at Bain & Company

Jeff Haxer is a globally recognized leader in Bain's Divestitures and Spin-offs product and a key figure in the Americas Healthcare and Life Sciences sector. With over 16 years of experience, Jeff has assisted top companies across a multitude of industries including pharmaceuticals, medical devices, automotive, insurance, retail, and agriculture. He specializes in M&A strategy, providing expert guidance on acquisition, divestiture, and spin-off transactions. Jeff has overseen 45+ due diligence assessments and advised on 35+ transactions worth a combined total of $260B+. Jeff holds an MBA from MIT Sloan School of Management and a BBA with honors from the University of Michigan.

Highlights

Dec 20 · linkedin

To realize increased shareholder value in a spinoff, companies must do more than just address entanglements. They must take advantage of the opportunity to change the performance of their business.

Feb 9 · linkedin

If it feels like Healthcare deals were really expensive in 2021, it's because deal multiples reached an all time high. It's more important than ever to invest in a really well thought out deal thesis during diligence and flow those key elements of value through your integration planning.

Jeff Haxer
Add to my network

Location

Chicago, Illinois, United States